Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin HCl in Advanced NSCLC with Cachexia
NCT03743064Phase 3Completed
- Sponsor
- Helsinn
- Start
- May 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of anamorelin in cachexia, anorexia nervosa (AN), sponsored by Helsinn. Started May 2019; status: completed.
02
Drugs
anamorelin
03
Conditions
cachexiaanorexia nervosa (AN)
Beyond the preview
Go deeper on NCT03743064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03743064.